STOCK TITAN

KORU Medical Systems to Report Third Quarter 2021 Financial Results on November 10, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

KORU Medical Systems (NASDAQ: KRMD) will report its third quarter 2021 financial results on November 10, 2021. Management will host a conference call at 4:30 p.m. ET to discuss the results and provide a corporate update. Participants can access the call via designated phone numbers based on location or via the company's Investor section. The archived webcast will be available for six months post-event, allowing stakeholders to stay informed about KORU Medical's performance and updates.

Positive
  • None.
Negative
  • None.

CHESTER, N.Y.--(BUSINESS WIRE)-- Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will report third quarter 2021 financial results on Wednesday, November 10, 2021. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Conference Call and Webcast Details

The conference call can be accessed by dialing (877) 300-8521 for participants in the U.S. or Canada and (412) 317-6026 for international callers, using conference ID 10160951. A live and archived webcast of the event can be accessed via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. The archived webcast will be available for six months.

About KORU Medical Systems

KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

Investor Contact:

Greg Chodaczek

347-620-7010

investors@korumedical.com

Source: KORU Medical Systems

FAQ

When will KORU Medical report its financial results for the third quarter 2021?

KORU Medical will report its financial results on November 10, 2021.

What time is the KORU Medical conference call for Q3 2021 results?

The conference call will take place at 4:30 p.m. ET.

How can investors access KORU Medical's conference call?

Investors can access the call by dialing specific phone numbers or through the company's Investor section on their website.

Will there be a recording of the KORU Medical conference call?

Yes, the archived webcast will be available for six months.

KORU Medical Systems, Inc.

NASDAQ:KRMD

KRMD Rankings

KRMD Latest News

KRMD Stock Data

143.07M
42.95M
6.3%
54.38%
1.06%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
MAHWAH